Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,543,941
+$6,358,414 QoQ
Shares Held
1,669,419
+0.5% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 183 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. DNA ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in DNA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,543,941 | 1,669,419 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,185,527 | 1,661,587 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $13,112,572 | 1,577,927 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $23,458,096 | 1,608,923 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,768,360 | 1,490,521 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,085,985 | 1,418,594 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,360,953 | 851,421 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $11,625,958 | 1,426,498 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $8,973,885 | 26,867,920 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $13,267,856 | 11,437,808 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,654,616 | 1,570,779 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,816,268 | 1,555,950 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,624,941 | 873,625 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $991,905 | 745,794 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,215,734 | 719,370 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,829,371 | 586,337 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $598,623 | 251,523 | Shares | Defined | 2022-08-22 | |
| No filing history on record for this holder in this stock. | ||||||